The Palico Private Equity Fund Marketplace
Mandarin Capital Management is a private equity general partner firm with offices in
Mandarin Capital Partners invested €16.4m from its second fund for a majority stake in Italy-based contract manufacturing firm Mipharm.
Mandarin Capital partner Markus Solibieda has left the Sino-Italian GP to join BASF Venture Capital as a MD.
Clessidra, Mandarin Capital Partners, Private Equity Partners and Dea Capital have sold Italian pharmaceutical ingredient producer Euticals.
Read more news concerning Mandarin Capital Management
A sampling of Mandarin Capital Management portfolio companies:
View all of the investments in their portfolio
Registration is fast, free and easy
Already a member?